Zyrtec Allergy Capsule, Liquid Filled
NDC Package 50580-786-40
Package Information
Zyrtec Allergy (cetirizine hydrochloride) capsules is adults and children 6 years and overone 10 mg capsule once daily; do not take more than one 10 mg capsule in 24 hours. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Kenvue Brands Llc, this product is identified by NDC 50580-786 and is authorized under FDA application ANDA213105.
Identification & Billing
- RxCUI: 1014675 - cetirizine HCl 10 MG 24HR Oral Capsule
- RxCUI: 1014675 - cetirizine hydrochloride 10 MG Oral Capsule
- RxCUI: 1014675 - cetirizine HCl 10 MG 24 HR Oral Capsule
- RxCUI: 1020023 - ZyrTEC 10 MG Oral Capsule
- RxCUI: 1020023 - cetirizine hydrochloride 10 MG Oral Capsule [Zyrtec]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50580 - Kenvue Brands Llc
- 50580-786 - Zyrtec Allergy
- 50580-786-40 - 1 BOTTLE in 1 PACKAGE / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 50580-786 - Zyrtec Allergy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (50580-786). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50580-786-40 identifies a specific commercial package of 1 bottle in 1 package / 40 capsule, liquid filled in 1 bottle of Zyrtec Allergy, a human over the counter drug labeled by Kenvue Brands Llc. This capsule, liquid filled is formulated for oral use and contains cetirizine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kenvue Brands Llc on April 15, 2024. The current certification is valid through December 31, 2026.
How is this Kenvue Brands Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50580078640. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.